Risk-based approaches to monitoring clinical trials were brought to the forefront with an FDA guidance published in 2013.
Risk-based approaches to monitoring clinical trials were brought to the forefront with an FDA guidance published in 2013.
Site Profile & Oversight Tool (SPOT) and Intelligent Medical Coding (IMC) unveiled by RBQM innovator at DIA Global Annual Meeting 2024 King of Prussia, PA –